Pacific Biosciences Of California, Inc. financial data

Symbol
PACB on Nasdaq
Location
1305 O'brien Drive, Menlo Park, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
NANOFLUIDICS INC (to 7/28/2004)
Latest financial report
10-K - Q4 2024 - Mar 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 859 % +98%
Quick Ratio 93.8 % +201%
Debt-to-equity 180 % +9.96%
Return On Equity -59 % -34.6%
Return On Assets -21 % -26.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 298M shares +9.36%
Common Stock, Shares, Outstanding 294M shares +9.96%
Entity Public Float 371M USD -88.8%
Common Stock, Value, Issued 294K USD +9.7%
Weighted Average Number of Shares Outstanding, Basic 274M shares +8.22%
Weighted Average Number of Shares Outstanding, Diluted 288M shares +13.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 40M USD -28.2%
Cost of Revenue 117M USD -21%
Research and Development Expense 135M USD -27.9%
Operating Income (Loss) -474M USD -41.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -310M USD +2.71%
Income Tax Expense (Benefit) 316K USD
Net Income (Loss) Attributable to Parent -310M USD -1.02%
Earnings Per Share, Basic -1.13 USD/shares +6.61%
Earnings Per Share, Diluted -1.59 USD/shares -31.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 55.4M USD -69.2%
Accounts Receivable, after Allowance for Credit Loss, Current 27.5M USD -24.8%
Inventory, Net 58.8M USD +3.67%
Assets, Current 496M USD -33.2%
Property, Plant and Equipment, Net 30.5M USD -16.3%
Operating Lease, Right-of-Use Asset 16.1M USD -50.6%
Intangible Assets, Net (Excluding Goodwill) 390M USD -14.8%
Goodwill 318M USD -31.3%
Other Assets, Noncurrent 9.31M USD -29.9%
Assets 1.26B USD -27.8%
Accounts Payable, Current 16.6M USD +10.1%
Employee-related Liabilities, Current 11.7M USD -60.1%
Accrued Liabilities, Current 22.6M USD -50.6%
Contract with Customer, Liability, Current 13.9M USD -15.2%
Liabilities, Current 66.3M USD -30.2%
Contract with Customer, Liability, Noncurrent 5.9M USD +6.69%
Operating Lease, Liability, Noncurrent 14.9M USD -52.8%
Other Liabilities, Noncurrent 546K USD -27.3%
Liabilities 754M USD -27.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 422K USD +92.7%
Retained Earnings (Accumulated Deficit) -2.15B USD -16.8%
Stockholders' Equity Attributable to Parent 507M USD -27.8%
Liabilities and Equity 1.26B USD -27.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -75.7M USD +20.1%
Net Cash Provided by (Used in) Financing Activities 6.55M USD -96.7%
Net Cash Provided by (Used in) Investing Activities -34.1M USD +53%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 294M shares +9.96%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -103M USD -459%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 57.6M USD -68.5%
Deferred Tax Assets, Valuation Allowance 559M USD +6.3%
Deferred Tax Assets, Gross 654M USD +1.73%
Operating Lease, Liability 24.9M USD -39.5%
Depreciation 3.24M USD +17.6%
Payments to Acquire Property, Plant, and Equipment 3.88M USD +4.25%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -310M USD -2.62%
Lessee, Operating Lease, Liability, to be Paid 27.4M USD -41.4%
Property, Plant and Equipment, Gross 112M USD +1.1%
Operating Lease, Liability, Current 10M USD +4.54%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.78M USD -28.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.5M USD -4.97%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +14.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.43M USD -56.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.11M USD -42.7%
Deferred Tax Assets, Operating Loss Carryforwards 434M USD -0.31%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 17.7M USD +21.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Additional Paid in Capital 2.65B USD +4.52%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 6.85M USD +2829%
Deferred Tax Assets, Net of Valuation Allowance 94.8M USD -18.8%
Share-based Payment Arrangement, Expense 71.6M USD -2.59%
Interest Expense 14.3M USD -2.29%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%